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The structure and regulation of voltage-
dependent calcium channels and their role in
inherited and toxicant-induced neurologic
disorders was the topic of a conference spon-
sored and hosted by the National Institute of
Environmental Health Sciences, the U.S.
Environmental Protection Agency, Sibia
Neurosciences, and the Muscular Dystrophy
Association on 6–8 December 1999. The
conference, “Calcium Channels: Critical
Targets of Toxicants and Diseases,” brought
together experts in a variety of disciplines to
discuss our current knowledge of calcium
channel structure and function, channel reg-
ulation by intracellular signaling molecules,
and the effects of mutations, aging, and toxi-
cants on channel function.
Calcium channels play important and
diverse roles in neurologic function. It has
been known for many years that calcium
channels are likely targets of a variety of
organic and inorganic toxicants. More recent-
ly, calcium channel mutations have been
implicated in several inherited neurologic dis-
orders, including migraine headaches, various
movement disorders, and some types of
malignant hyperthermia. The last decade has
seen great strides in determining the subunit
structure of calcium channels, how the genet-
ic diversity of subunits generates a variety of
functionally distinct channels, and how intra-
cellular signaling pathways regulate channel
function. The meeting was convened to guide
future research by applying this knowledge of
calcium channel biology to further our under-
standing of how toxicants and mutations alter
channel functions. 
The presentations discussed four major
aspects of calcium channels that are relevant
for understanding their roles in genetic and
environmental neurologic disorders: the
genetics and molecular biology of channel
structure; interactions between calcium chan-
nels and intracellular signaling pathways; the
effects of toxicants on calcium channel func-
tion, both through direct interactions with
channel subunits and by altering intracellular
signaling; and the genetics, molecular biolo-
gy, and physiology of inherited disorders
caused by mutations in the genes encoding
calcium channel subunits or from autoim-
mune disorders caused by the generation of
antibodies against subunits of those proteins.
Structure and Function of
Calcium Channels
Voltage-dependent calcium channels are
composed of four principal subunits: the
transmembrane, pore-forming α 1 subunits
and three accessory subunits that modulate
channel function—the glycosylated α 2δ
subunits, the integral membrane γ subunits,
and the cytoplasmic β subunits. There are
several isoforms of each of these channel
subunits, and the composition of the chan-
nel complex determines its expression level,
localization, kinetics, and pharmacology. 
Ten genes on nine different chromo-
somes encode the α 1 subunits. Diversity of
α 1 subunits gives rise to the familiar classiﬁ-
cation of calcium channels (i.e., L, N, T,
P/Q, R) on the basis of channel kinetics,
cation permeability, and pharmacology.
Several human disorders have been traced to
mutations in the α 1 subunit genes, includ-
ing familial hemiplegic migraine, several
types of ataxia, hypokalemic periodic paraly-
sis, and malignant hyperthermia. In most
cases, it remains to be established how the
mutations produce pathology.
The accessory subunits (α 2δ , β , and γ )
regulate the expression, localization, kinetics,
and modulation of calcium channels, but
relatively little is known of the molecular
mechanisms involved. In mice, mutations in
the β 4 (lethargic) and γ 2 (stargazer) sub-
units, prominently expressed in cerebellar
Purkinje neurons, produce ataxia. Recently,
Escayg et al. (1) reported that mutations in
the β 4 subunit are associated with some
forms of epilepsy and episodic ataxia. It thus
appears likely that a variety of human neuro-
logic disorders may be attributable to muta-
tions in the accessory subunits. 
Studies of mice with mutant channel
subunits are providing clues both to normal
channel assembly and to the effects of altered
channel function. Of particular importance
for the theme of this meeting is that alter-
ations in the expression of one channel sub-
unit are often partially compensated for by
changes in expression of other subunits. For
example, the absence of the β 4 subunit in
the lethargic mutant mouse causes increased
expression of the β 1B subunit despite a
decrease in the total pool of β subunit 
protein. The absence of α 1A subunits results
in decreased expression of β 4 subunits and
increases in β 1B subunits. Nevertheless, 
animals with either mutation show clear
pathologic phenotypes, suggesting that com-
pensatory changes in expression of calcium
channel subunits are limited in their ability
to restore normal neuronal function.
Further, at least some of these compensatory
changes may themselves cause cellular dys-
function. This principle, that a primary
defect in calcium channel function, either
genetic, autoimmune, or toxicant-induced,
may produce both “primary” symptoms and
a constellation of “secondary” symptoms
caused by other, possibly compensatory,
changes in neuronal physiology, was repeat-
ed several times in various contexts during
the presentations.
Calcium channel expression also changes
with normal aging. For example, in hip-
pocampal neurons, the expression of L-type
channels increases with age. This increase in
L-type channels is correlated with increased
failure of excitatory postsynaptic potentials as
well as increased susceptibility to cell death.
At the whole-animal level, these changes are
correlated with decreased performance on
spatial learning tasks. Up-regulation of the
expression of the α 1D subunit appears to
underlie the increased expression of L-type
channels in hippocampal neurons with age;
much smaller increases in expression of α 1C,
and no change in the expression of β 1B sub-
units are observed. This age-related change in
channel expression may make the nervous
system more susceptible to both pathologic
and toxicologic insult.
Interactions between Calcium
Channels and Intracellular
Signaling
The activity of calcium channels is regulated
by a wide variety of intracellular signaling
pathways. Probably the three most well
understood are binding and activation of
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tein kinases, and binding of G protein βγ
subunits. These pathways not only modulate
calcium channel activity, all are themselves
modulated in various ways by calcium inﬂux
through calcium channels, and many inter-
act with one another. Thus, complex feed-
back mechanisms among calcium channels
and intracellular signaling exist and are likely
targets for both environmental and genetic
disorders.
Calcium channels play key, but far from
exclusive, roles in regulating intracellular 
calcium homeostasis. Both pathologic condi-
tions (stroke, ischemia, AIDS, etc.) and toxi-
cologic insult (e.g., by methylmercury, lead)
produce alterations in calcium homeostasis
that can lead to neuronal death. Calcium
inﬂux through both voltage- and ligand-gated
channels (e.g., the N-methyl-D-aspartate
receptor) contributes to alterations in calcium
homeostasis, but other intracellular organelles
and calcium ATPases also are part of the
machinery responsible for regulation of calci-
um homeostasis. These intracellular calcium
stores and ATPases interact with channel-
mediated calcium entry to give rise to locally
conﬁned calcium increases, or responses such
as calcium spikes or waves. The amplitude,
time course, and intracellular distribution of
calcium signals are important determinants of
the cellular response. All aspects of cellular
calcium homeostasis are likely targets for dis-
eases and toxicant-induced disorders.
Calmodulin, a ubiquitous calcium-bind-
ing protein, has long been known to mediate
many of the intracellular effects of calcium
inﬂux through calcium channels, especially
L-type channels. For example, calcium entry
via the L-type channel appears to be critical
for activation of a number of different tran-
scriptional pathways, including those mediat-
ed by CREB [cyclic AMP response element
binding (protein)], NF-AT (nuclear factor of
activated T-cell), and p38 MAP (mitogen-
activated protein) kinase. More recently,
calmodulin has also been found to act in the
feedback regulation of calcium entry through
L-type channels. Calmodulin binds to the
intracellular carboxy terminal of the α 1C
subunit. Calcium entering through the chan-
nel binds to this calmodulin and reduces fur-
ther calcium inﬂux. Thus calmodulin can act
as a key molecule both in stimulation of gene
transcription and other cellular events and in
feedback inhibition of calcium channels.
Calcium channels may be phosphorylat-
ed by many protein kinases, including calci-
um/calmodulin-dependent protein kinases
and protein kinases A and C. The effects of
such phosphorylation depend on the chan-
nel subtype under study, the protein kinase,
and other signaling pathways that may be
active. In recent years considerable progress
has been made in understanding the molecu-
lar mechanisms of G protein modulation of
calcium channels (particularly the N-type, or
α 1B, channels). The intracellular amino ter-
minal of the α 1B subunit has been shown to
be essential for G protein effects, but β
channel subunits are also required for regula-
tion by G protein βγ subunits. Interactions
among all of these intracellular pathways also
abound. For example, G protein binding to
calcium channels may be modulated by
channel phosphorylation.
The Effects of Toxicants on
Channel Function
There are two fundamentally different mech-
anisms whereby neurotoxicants might alter
calcium channel function: by direct interac-
tion with channel subunits (e.g., occluding
the pore) or by interaction with intracellular
signaling pathways that modulate channel
activity. Interactions with the channel sub-
units themselves are well known—for exam-
ple, heavy metals blocking the pore. Although
there is a substantial literature describing
effects of neurotoxicants on intracellular sig-
naling, relatively little is known about how
such effects might modulate calcium channel
activity. The time appears to be ripe for a sig-
niﬁcant research effort to study the interac-
tions among toxicants, intracellular signaling
pathways, and calcium channel activity. 
Several papers presented at the meeting
discussed the effects of specific toxicants
[methylmercury, inorganic lead, polychlori-
nated biphenyls (PCBs), and ethanol] on
calcium channels. Interestingly, all of these
toxicants, with the possible exception of
PCBs, appear to have effects both directly on
channels and indirectly via intracellular sig-
naling. Unfortunately, studies of toxicant
effects on calcium channels have used a vari-
ety of cell types and experimental approaches,
so that unambiguous comparisons among
toxicants are often difficult or impossible.
Nevertheless, several generalizations can be
drawn from the presentations at the meeting.
First, it has long been known that many
heavy metals impair current flow through
calcium channels, mostly by blocking the
pore. However, many metals, in both inor-
ganic and perhaps especially in organic form,
have other effects, presumably often mediat-
ed through intracellular signaling. Lead is
perhaps the best studied of all toxicants with
actions on calcium channels. Inhibition of
channel current has been demonstrated for
acute exposure to low micromolar concen-
trations of lead in virtually every preparation
in which it has been examined, presumably
due to blocking the pore. However, lead
may also enter the cell through some types of
calcium channels (particularly the L-type
channel). Intracellular lead may promote
channel activity by attenuating the normal
channel inactivation by intracellular calcium.
This effect occurs at much lower lead concen-
trations (picomolar to nanomolar) than are
required for blocking the pore. Intracellular
lead may also activate protein kinase C and
various calmodulin-dependent enzymes, such
as calmodulin-dependent protein kinase,
phosphodiesterase, and calcineurin, at pico-
molar concentrations. The impacts of such
actions on calcium channel activity, or on the
pathways that are normally activated by calci-
um inﬂux through calcium channels, remain
largely unknown. 
Methylmercury provides another example
of complex interactions of toxicants with cal-
cium channels. Unlike most inorganic heavy
metals, methylmercury is lipophilic and may
permeate cells directly through the phospho-
lipid bilayer or as a cysteine complex and
exert intracellular effects in addition to block-
ing the channel pore. For example, although
acute, externally applied methylmercury
blocks calcium channels, the block is slowly
and incompletely reversible. The lack of
reversibility may be the result of prolonged
residence in the phospholipid bilayer or the
cytoplasm due to the lipophilicity of this
organometal, or due to the relatively greater
reactivity of methylmercury with sulfhydryl
groups on calcium channels. Prolonged expo-
sure (6 days) of PC12 cells to nanomolar con-
centrations of methylmercury reduces whole
cell calcium currents; it is not known whether
this decrease in current is caused by direct
effects of methylmercury on calcium chan-
nels, or to indirect effects, such as altering
channel density.
Voltage-gated calcium channels are also
prominent targets of ethanol. Acute exposure
to ethanol inhibits the function of both L-
and N-type calcium channels in several neu-
ronal systems. The mechanisms associated
with impaired function of L-type channels
involve decreased open channel probability
and enhanced inactivation of the channel.
With chronic exposure to ethanol, the densi-
ty of L- and N-type calcium channels
increases in PC12 cells and in rodent brain.
Up-regulation of L-type channels is thought
to contribute to the enhanced neuronal
excitability seen during ethanol withdrawal;
up-regulation of N-type channels would be
expected to enhance transmitter release. Both
effects could contribute to the behavioral
hyperexcitability seen during ethanol with-
drawal. The up-regulation of L- and N-type
calcium channels in PC12 cells by ethanol is
due in part to effects on protein kinase C
(PKC); chronic exposure to ethanol increases
PKC-mediated phosphorylation and the
abundance of PKC δ and ε isozymes.
Interestingly, inhibiting PKC δ prevents up-
regulation of L-type channels by ethanol,
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tion of N-type channels. Thus acute exposure
to ethanol inhibits the function of two classes
of voltage-gated calcium channels, whereas
chronic exposure induces up-regulation of
these channels by PKC-dependent mecha-
nisms that involve different PKC isozymes.
The effects of PCBs on the ryanodine
receptor provide an illustration of complex
effects of toxicants on calcium channels.
Ryanodine receptors mediate calcium-
induced calcium release from the endoplasmic
reticulum. Calcium influx through plasma
membrane calcium channels is an important
trigger for calcium-induced calcium release;
the calcium released from intracellular stores
may then cause calcium-induced inactivation
of the channels (perhaps via calmodulin; see
above). Some non-coplanar PCBs impair the
function of the ryanodine receptor and alter
intracellular calcium regulation. This would
be expected to alter calcium channel function
as well, but such effects, if they occur, remain
unknown.
Neurologic Disorders
Mediated by Calcium
Channels 
A diverse set of clinical syndromes is associ-
ated with mutations in the genes encoding
the various calcium channel subunits. Some
of the disorders affect skeletal muscle or the
neuromuscular junction, such as hypokalemic
periodic paralysis (HypoKPP) and Lambert-
Eaton myasthenic syndrome (LEMS). Other
diseases affect the central nervous system,
such as familial hemiplegic migraine (FHM),
episodic ataxia type 2 (EA-2), and spinocere-
bellar ataxia type 6 (SCA6). Interestingly,
some features seem to be shared by most of
the clinical syndromes: 
• Most syndromes have episodic features:
muscle weakness, ataxia, or migraine
attacks
• All syndromes have some features that are
chronic and/or progressive, such as muscle
damage or cerebellar atrophy
• There seems to be a gradual superimposi-
tion of permanent deficits on initially
episodic deﬁcits. One exception seems to
be SCA6, which lacks episodic features
• All genetic syndromes show reduced pene-
trance, in that not all carriers of a given
mutation are affected clinically, and there
is considerable variation in the symptoms.
Without doubt, other genetic and/or envi-
ronmental factors are involved in all of the
channelopathies
• Several syndromes are responsive to azetozo-
lamide. Somehow, changing the pH in the
extracellular environment and/or blocking
the channel pores by the binding of protons
seems to affect these channelopathies
• Some general triggers such as stress, fatigue,
or certain foods seem to precipitate attacks
in different syndromes. 
Sometimes the same syndrome is caused
by mutations in different genes [e.g., muta-
tions in the ryanodine receptor (RYR1) or the
α 1S calcium channel cause malignant hyper-
thermia], and sometimes mutations in the
same gene are associated with different clinical
syndromes (FHM and EA-2 are both caused
by mutations in the α 1A calcium channel
subunit). This leads to the tantalizing sugges-
tion that trigger or threshold factors might be
shared by all or most channelopathies. It will
be a major challenge to reveal those common
factors. From various presentations during the
meeting, it appears that steroid hormones,
alcohol, and heavy metals may be candidates
worth pursuing. 
Several speakers highlighted the difﬁcul-
ties of determining physiologic mechanisms
for calcium channelopathies. For example,
some types of FHM appear to be caused by
mutations in the gene encoding the α 1A
(P/Q) subunit. Recent electrophysiologic
experiments in embryonic kidney cells trans-
fected with FHM genes show that the
mutated genes alter channel kinetics.
However, some of the mutations decreased
channel density and conductance, leading to
reduced calcium inﬂux, whereas other muta-
tions caused an increased channel density
and increased open probability, leading to
increased calcium inﬂux.
A second example of the difficulty of
merging clinical and molecular/physiologic
studies is illustrated by EA-2. Until recently,
EA-2 was thought to be associated with
truncating mutations in the α 1A gene.
However, missense mutations have now
been found as well. Further, the severity of
the clinical phenotype can dramatically dif-
fer between various mutations. For instance,
the Gly293Arg mutation is associated with a
severe progressive ataxia, whereas other
mutations associated with EA-2 are less pro-
gressive. Finally, two apparently different
syndromes may be caused by the same muta-
tion (i.e., the same mutation of α 1A may
cause EA-2 and SCA6). 
HypoKPP provided a third example of
the promise and difficulties of genetic and
physiologic analysis of channelopathies.
HypoKPP is caused by three different muta-
tions in the calcium channel subunit α 1S
(skeletal muscle L-type channel). All three
known mutations cause substitutions for pos-
itively charged arginine residues in the S4
transmembrane domains, which are regions
implicated in voltage sensing. These muta-
tions appear to cause reduced current density.
It is not understood how reduced calcium
currents are related to some of the symptoms
of HypoKPP, such as muscle depolarization
and reduced serum potassium. 
LEMS combines features of both toxi-
cant-induced and inherited channelopathies.
It is believed that LEMS begins with an
autoimmune response, often evoked by
small cell lung cancer. One of the main
immunogens is a P/Q-type channel compo-
nent, probably because P/Q channels are
highly expressed on these tumor cells.
Circulating autoantibodies recognize P/Q-
type channels present at the neuromuscular
junction, where they destroy the active zones
of nerve terminals, leading to reduced acetyl-
choline release. A LEMS-like disorder can be
elicited in mice by repeated administration
of serum, plasma, or immunoglobulins from
affected patients. In LEMS immunoglobulin-
treated mice, there is a reduction in the
amplitude of calcium currents and frequency-
dependent facilitation. Mostly P/Q and N-
type channels normally carry these calcium
currents, but in LEMS immunoglobulin-
treated mice an additional L-type current has
been identiﬁed. Thus, there appears to be a
down-regulation of normally expressed chan-
nels and a compensatory up-regulation of L-
type channels. It is not known whether such
changes in channel expression occur in
human LEMS patients. 
Conclusions and Future
Directions
Two dominant themes emerged from the
meeting. First, we are in an excellent position
to apply our knowledge of the molecular biol-
ogy and physiology of calcium channels to
detailed analyses of genetic defects and toxi-
cant effects. Second, the complex interplay
among calcium channels, calcium influx,
intracellular calcium homeostasis, and intra-
cellular signaling is likely to be important
both in clinical syndromes attributable to cal-
cium channel mutations and in the neurolog-
ic effects of a variety of toxicants. Although
these two themes are not completely indepen-
dent, it is useful to discuss them separately.
Within each theme, implications for future
research in understanding clinical syndromes
and neurotoxicant effects will be considered.
Molecular biology and physiology of cal-
cium channels. The variety of physiologically
deﬁned calcium channels is now becoming
understood at the molecular level. Multiple
isoforms of each of the subunits have now
been identified, cloned, and sequenced (or
will be soon). Studies of calcium channel
subunit mutations, both in humans and in
animal models, will be important in two dif-
ferent ways. First, and most obviously,
understanding the electrophysiologic and
cellular consequences of subunit mutations
provides at least the potential to design
novel, rational treatments that may alleviate
the symptoms brought on by the inherited
channel defects. Such treatments may be
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“downstream” intracellular effects (e.g., on
calcium homeostasis or intracellular signal-
ing pathways). The possible necessity of
downstream interventions is highlighted by
the fact that similar clinical syndromes may
be caused by mutations with different effects
on channel physiology, and different syn-
dromes may be elicited by the same muta-
tion. Second, electrophysiologic analyses of
cells transfected with known subunit combi-
nations, mutated subunits (either naturally
occurring or generated by site-directed muta-
genesis), and subunits derived from mutant
mouse lines will identify key amino acid
residues that regulate voltage dependence,
channel kinetics, pharmacologic sensitivity,
and modulation by intracellular signaling
pathways in normal channels. Such analyses,
often initially driven by the need to under-
stand the basis of clinical syndromes, have
already provided important information
about basic channel physiology and offer
great promise for the future.
In neurotoxicologic studies, calcium
channel diversity should be viewed as an
opportunity, not an obstacle. Studies of
channel subunit mutations have clearly
shown that different effects, both on the cel-
lular and whole-animal levels, occur when
different subunits, or different isoforms of
the same subunit (especially the α 1 subunits)
malfunction. It is quite likely that some toxi-
cants preferentially target certain subunits
and/or isoforms. Such toxicant selectivity can
now be directly analyzed in cells transfected
with cloned subunits, rather than by trying to
use pharmacologic tools to tease apart effects
in cells expressing many channel types.
Several presenters noted that the progres-
sion and severity of clinical syndromes vary
considerably even within a population bearing
the same mutated subunit gene, suggesting
that environmental factors may modulate the
threshold at which a mutated subunit pro-
duces clinical effects. It would be extremely
useful, both for clinicians and for neurotoxi-
cologists, to determine if interactions between
toxicants and already-defective channels
might hasten the onset or increase the severity
of symptoms.
Calcium channel regulation, calcium
homeostasis, and intracellular signaling.
Several speakers pointed out that calcium
channels both regulate and are regulated by
intracellular calcium homeostasis and intra-
cellular signaling pathways. Further, channel
regulation occurs both acutely (e.g., through
changes in channel activity by phosphoryla-
tion or G protein binding) and chronically
(e.g., up- or down-regulation of channel
density). Bidirectional regulation may have
profound implications for treating genetic
calcium channelopathies. First, in many
cases the clinical symptoms are caused, not
directly by altered channel function per se,
but by altered cellular metabolism caused by
channel dysfunction. Therefore, understand-
ing the actual cause of the symptomatology
and/or designing treatments will require an
understanding of the signaling pathways
downstream of calcium channel dysfunction.
Indeed, it may well be found that some of
the symptoms of clinical syndromes not cur-
rently thought to be mediated by calcium
channels may arise because defective intra-
cellular signaling alters the function of genet-
ically normal channel subunits. Second, cells
often up- or down-regulate various channel
subunits in response to dysfunction of a
given subunit, and the resulting changes in
channel types and densities may ameliorate
and/or contribute signiﬁcantly to the clinical
symptoms. The mechanisms underlying
changes in channel expression, largely
unknown at the present time, are likely to be
found in the interplay among channel func-
tion, intracellular calcium homeostasis, and
intracellular signaling pathways.
Neurotoxicants may affect calcium chan-
nel function either by directly interacting with
the channel subunits or by altering intracellu-
lar pathways that regulate channel subunits. A
large number of toxicants are known to alter
intracellular signaling pathways and/or alter
calcium homeostasis, but how these effects
impact calcium channel function remains
largely unexplored. Such studies are feasible
and important. As noted above, in individuals
bearing mutated channel subunit genes, toxi-
cants may reduce the threshold at which cel-
lular and organismal dysfunction occurs.
These effects may well originate through
actions on altered intracellular signaling rather
than directly on the channel subunits them-
selves. It should be noted that aging also
changes calcium channel subunit density and
susceptibility to insult (e.g., ischemia or
excitotoxicity). Although considerable neuro-
toxicologic research has focused on the devel-
oping nervous system, much less attention has
been paid to the aging nervous system, which
probably also has a unique pattern of suscepti-
bility to toxicants. Interactions between
altered intracellular signaling during aging
and toxicant exposure, particularly long-term,
cumulative exposure, may promote age-relat-
ed neurologic dysfunction. 
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